HUT59911A - Process for producing azol-derivatives of cycloalkylenes and pharmaceutical compositions containing them - Google Patents

Process for producing azol-derivatives of cycloalkylenes and pharmaceutical compositions containing them

Info

Publication number
HUT59911A
HUT59911A HU9200324A HU32490A HUT59911A HU T59911 A HUT59911 A HU T59911A HU 9200324 A HU9200324 A HU 9200324A HU 32490 A HU32490 A HU 32490A HU T59911 A HUT59911 A HU T59911A
Authority
HU
Hungary
Prior art keywords
image
well
methods
cycloalkylenes
azol
Prior art date
Application number
HU9200324A
Other languages
English (en)
Other versions
HU9200324D0 (en
Inventor
Rolf Bohlmann
Peter Strehlke
David Henderson
Martin Schneider
Yukishige Nishino
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of HU9200324D0 publication Critical patent/HU9200324D0/hu
Publication of HUT59911A publication Critical patent/HUT59911A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
HU9200324A 1989-08-04 1990-08-06 Process for producing azol-derivatives of cycloalkylenes and pharmaceutical compositions containing them HUT59911A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3926365A DE3926365A1 (de) 1989-08-04 1989-08-04 Cycloalkylenazole, verfahren zu deren herstellung, pharmazeutische praeparate, die diese enthalten sowie ihre verwendung zur herstellung von arzneimitteln

Publications (2)

Publication Number Publication Date
HU9200324D0 HU9200324D0 (en) 1992-04-28
HUT59911A true HUT59911A (en) 1992-07-28

Family

ID=6386820

Family Applications (2)

Application Number Title Priority Date Filing Date
HU9200324A HUT59911A (en) 1989-08-04 1990-08-06 Process for producing azol-derivatives of cycloalkylenes and pharmaceutical compositions containing them
HU9200324A HU217126B (hu) 1989-08-04 1990-08-06 Eljárás cikloalkilének azolszármazékai és az ezeket tartalmazó gyógyszerkészítmények előállítására

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU9200324A HU217126B (hu) 1989-08-04 1990-08-06 Eljárás cikloalkilének azolszármazékai és az ezeket tartalmazó gyógyszerkészítmények előállítására

Country Status (19)

Country Link
US (3) US5135937A (hu)
EP (1) EP0411735B1 (hu)
JP (1) JP3207417B2 (hu)
CN (1) CN1024345C (hu)
AT (1) ATE122662T1 (hu)
AU (1) AU634266B2 (hu)
CA (1) CA2022682C (hu)
DD (1) DD296917A5 (hu)
DE (2) DE3926365A1 (hu)
DK (1) DK0411735T3 (hu)
ES (1) ES2074530T3 (hu)
FI (1) FI920425A0 (hu)
HU (2) HUT59911A (hu)
IE (1) IE902843A1 (hu)
IL (1) IL95279A (hu)
NO (1) NO301115B1 (hu)
PT (1) PT94884B (hu)
WO (1) WO1991001975A1 (hu)
ZA (1) ZA906150B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5112845A (en) * 1986-03-07 1992-05-12 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US5352795A (en) * 1986-03-07 1994-10-04 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
TW224461B (hu) * 1990-09-18 1994-06-01 Ciba Geigy Ag
DE4107038A1 (de) * 1991-03-01 1992-09-03 Schering Ag Triheteroarylmethane, verfahren zu deren herstellung, pharmazeutische praeparate die diese enthalten sowie ihre verwendung zur herstellung von arzneimitteln
DE4120107A1 (de) * 1991-06-14 1992-12-17 Schering Ag Bicyclisch substituierte vinylimidazole, -triazole und -tetrazole
DE4435368A1 (de) * 1994-09-22 1996-03-28 Schering Ag Verwendung von Aromatasehemmern zur Herstellung eines Arzneimittels zur Behandlung eines relativen Androgenmangels beim Mann
ZA9510926B (en) 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
WO2001012206A2 (de) * 1999-08-13 2001-02-22 Heinrich Wieland Soja-glycine extracten und aromatase-hemendern zur positiven beeinflussung von kollagen
EP1871750A1 (en) * 2005-07-06 2008-01-02 Sicor, Inc. Improved process for the preparation of letrozole
CN100425621C (zh) * 2006-07-06 2008-10-15 云南大学 甾体咪唑盐类化合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4609666A (en) * 1984-06-18 1986-09-02 Eli Lilly And Company Aromatase inhibiting derivatives of α,α-bis(4-halophenyl)methyltetrazoles and triazoles
JPS62149666A (ja) * 1985-12-25 1987-07-03 Shionogi & Co Ltd Ｎ−ビニルアゾ−ル類
US4749713A (en) * 1986-03-07 1988-06-07 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles

Also Published As

Publication number Publication date
IL95279A0 (en) 1991-06-30
WO1991001975A1 (de) 1991-02-21
DE3926365A1 (de) 1991-02-07
DE59009084D1 (de) 1995-06-22
CA2022682A1 (en) 1991-02-05
ZA906150B (en) 1991-05-29
US5135937A (en) 1992-08-04
CA2022682C (en) 1997-01-21
JP3207417B2 (ja) 2001-09-10
DD296917A5 (de) 1991-12-19
FI920425A0 (fi) 1992-01-30
ES2074530T3 (es) 1995-09-16
CN1049157A (zh) 1991-02-13
NO920432D0 (no) 1992-02-03
PT94884A (pt) 1991-04-18
EP0411735A1 (de) 1991-02-06
NO301115B1 (no) 1997-09-15
HU217126B (hu) 1999-11-29
AU6019490A (en) 1991-02-07
AU634266B2 (en) 1993-02-18
US5280035A (en) 1994-01-18
ATE122662T1 (de) 1995-06-15
US5411982A (en) 1995-05-02
JPH05501104A (ja) 1993-03-04
HU9200324D0 (en) 1992-04-28
NO920432L (no) 1992-02-03
CN1024345C (zh) 1994-04-27
EP0411735B1 (de) 1995-05-17
PT94884B (pt) 1997-04-30
IL95279A (en) 1995-03-30
DK0411735T3 (da) 1995-10-16
IE902843A1 (en) 1991-02-27

Similar Documents

Publication Publication Date Title
ES8506677A1 (es) Un procedimiento para la preparacion de nuevos derivados de 8-cloro71,5-benzotiazepina.
GEP20094816B (en) Morpholinoethylester of mycophenolic acid and derivatives thereof, their preparation and use in pharmaceutical compositions
GB8334494D0 (en) Carbostyril derivatives
HUT59911A (en) Process for producing azol-derivatives of cycloalkylenes and pharmaceutical compositions containing them
PT77370A (en) Process for preparing new pyrazolo <3,4-b> piridine derivatives and pharmaceutical preparations containing the same
ES484718A1 (es) Un procedimiento para la preparacion de benzopiranos.
AU578755B2 (en) Novel 9-chloro-1,5-benzothiazepine derivatives and processes for preparing the same
IE43278L (en) Diphenyl sulfides.
ES454063A1 (es) Un procedimiento para la preparacion de nuevos derivados delalcohol bencilico.
EP0066909A3 (en) Imidazole derivatives, pharmaceutical compositions containing them and processes for their production
HUT49581A (en) Process for producing imidazole derivatives and pharmaceutical compositions comprising same
ES474367A1 (es) Procedimiento de preparacion de nuevos derivados del benzo- (d)tiazol.
ES2018403A6 (es) Procedimiento para preparar nuevas 2-carbonil sustituido-n, n' -di(trimetoxibenzoil) -piperazinas.
ES8502424A1 (es) Procedimiento para la preparacion de derivados de benzazepina
GR860045B (en) Novel piperazine derivatives processes for production thereof and pharmaceutical compositions comprising said compounds as active ingredient
ES8704463A1 (es) Procedimiento para preparar 2-(n-alquinil-n-fenilamino)-imidazolinas
DE3367209D1 (en) Aminoethoxybenzylalcohol derivatives, process for their preparation and pharmaceutical compositions containing them
ES8104198A1 (es) Un procedimiento para la preparacion de un derivado de mo- noamida del acido tereftalico
MY101746A (en) 1,5-benzothiazepine derivatives, a process for preparing the same, pharmaceutical compositions as well as the use thereof.
EP0324184A3 (en) 2-amino-1,2,3,4-tetrahydroisoquinoline derivatives, method for their preparation and their use as medicines
ES485333A1 (es) Procedimiento para preparar derivados 5,6,7,8-tetrahidro-4 (3h)-quinazolinonicos y sus sales
ES8600232A1 (es) Procedimiento para preparar bencenos sustituidos.